Treatment options for HER2-expressing colorectal cancer: updates and recent approvals
Colorectal cancer is a leading cause of cancer-related mortality worldwide. Approximately 3–5% of colorectal tumors harbor human epidermal growth factor receptor ( HER2) amplification which is associated with a higher incidence of intracranial metastasis and overall worse outcomes. In the setting of...
Uloženo v:
Hlavní autoři: | , |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2024
|
On-line přístup: | https://doi.org/10.1177/17588359231225037 https://journals.sagepub.com/doi/pdf/10.1177/17588359231225037 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|